RecruitingNot ApplicableNCT07552701

USG-Guided TAPA vs RIFB Block for Postoperative Analgesia in Laparoscopic Cholecystectomy

Comparison of Ultrasonography-Guided the Postoperative Analgesic Efficacy of Perichondrial Approach Modified Thoracoabdominal Nerve Block and Recto-Intercostal Fascial Plan Block in Patients Who Underwent Laparoscopic Cholecystectomy


Sponsor

Hitit University

Enrollment

70 participants

Start Date

Mar 16, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Laparoscopic cholecystectomy (LC) can cause moderate-to-severe postoperative pain from visceral, referred shoulder, and incisional sources. Multimodal analgesia is recommended, but opioids carry significant side effects. Ultrasound-guided interfascial plane blocks offer a safe alternative. The Modified Thoracoabdominal Nerve Block through Perichondrial Approach (M-TAPA) blocks T5-T12 dermatomes, while the Recto-Intercostal Fascial Plane Block (RIFPB) provides sensory blockade across the upper anterolateral abdomen. This study compares the postoperative analgesic efficacy of bilateral M-TAPA versus bilateral RIFPB in patients undergoing LC.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria8

  • Age 18-65 years
  • ASA physical classification I-II
  • BMI < 35 kg/m²
  • Scheduled for elective laparoscopic cholecystectomy due to cholelithiasis
  • Able to use and understand the NRS pain scoring system
  • Able to use and understand the QoR-15 scale
  • Able to communicate in Turkish
  • Provided written informed consent

Exclusion Criteria24

  • Refusal to participate in the study
  • BMI > 35 kg/m²
  • ASA physical classification III-V
  • Age < 18 or > 65 years
  • Allergy to local anesthetics or study analgesics
  • Pregnancy or breastfeeding
  • Inability to use or understand the NRS pain scoring system or QoR-15 scale
  • Inability to communicate in Turkish
  • Uncontrolled anxiety disorder
  • Alcohol or drug dependency
  • Neuromuscular or peripheral nerve disease
  • High-dose opioid use within 3 days prior to surgery
  • Widespread chronic pain
  • Diabetes mellitus
  • Hepatic or renal insufficiency
  • Coagulation disorders or anticoagulant use
  • Infection at the block needle insertion site
  • Concurrent second surgical procedure alongside laparoscopic cholecystectomy
  • Previous abdominal surgery or trauma history
  • Conversion from laparoscopic to open surgery
  • Technical problems with the PCA device
  • NRS score > 7 for four consecutive hours despite multimodal analgesia
  • Planned postoperative non-extubation
  • Termination of surgery before completion for any reason

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREM-TAPA Group

Patients receiving ultrasound-guided bilateral Modified Thoracoabdominal Nerve Block through Perichondrial Approach (M-TAPA) using 20 ml of 0.25% bupivacaine per side, applied at the 10th rib level beneath the costochondral perichondrium after surgery while under anesthesia.

PROCEDURERIFPB Group

Patients receiving ultrasound-guided bilateral Recto-Intercostal Fascial Plane Block (RIFPB) using 20 ml of 0.25% bupivacaine per side, injected into the interfascial plane between the rectus abdominis muscle and the 6th-7th costal cartilages just below the xiphoid process, applied after surgery while under anesthesia.


Locations(1)

Hitit University

Çorum, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07552701


Related Trials